JP2023509462A5 - - Google Patents

Info

Publication number
JP2023509462A5
JP2023509462A5 JP2022541283A JP2022541283A JP2023509462A5 JP 2023509462 A5 JP2023509462 A5 JP 2023509462A5 JP 2022541283 A JP2022541283 A JP 2022541283A JP 2022541283 A JP2022541283 A JP 2022541283A JP 2023509462 A5 JP2023509462 A5 JP 2023509462A5
Authority
JP
Japan
Prior art keywords
seq
pharmaceutical composition
protein
active site
thioredoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022541283A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023509462A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/012109 external-priority patent/WO2021138682A1/en
Publication of JP2023509462A publication Critical patent/JP2023509462A/ja
Publication of JP2023509462A5 publication Critical patent/JP2023509462A5/ja
Priority to JP2025116559A priority Critical patent/JP2025182217A/ja
Pending legal-status Critical Current

Links

JP2022541283A 2020-01-03 2021-01-04 チオレドキシン活性を有する組成物および関連方法 Pending JP2023509462A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025116559A JP2025182217A (ja) 2020-01-03 2025-07-10 チオレドキシン活性を有する組成物および関連方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062956994P 2020-01-03 2020-01-03
US62/956,994 2020-01-03
PCT/US2021/012109 WO2021138682A1 (en) 2020-01-03 2021-01-04 Compositions having thioredoxin activity and related methods

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025116559A Division JP2025182217A (ja) 2020-01-03 2025-07-10 チオレドキシン活性を有する組成物および関連方法

Publications (2)

Publication Number Publication Date
JP2023509462A JP2023509462A (ja) 2023-03-08
JP2023509462A5 true JP2023509462A5 (cg-RX-API-DMAC7.html) 2024-08-27

Family

ID=76687128

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022541283A Pending JP2023509462A (ja) 2020-01-03 2021-01-04 チオレドキシン活性を有する組成物および関連方法
JP2025116559A Pending JP2025182217A (ja) 2020-01-03 2025-07-10 チオレドキシン活性を有する組成物および関連方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025116559A Pending JP2025182217A (ja) 2020-01-03 2025-07-10 チオレドキシン活性を有する組成物および関連方法

Country Status (6)

Country Link
US (1) US20230071765A1 (cg-RX-API-DMAC7.html)
EP (1) EP4084867A4 (cg-RX-API-DMAC7.html)
JP (2) JP2023509462A (cg-RX-API-DMAC7.html)
CN (1) CN115315292A (cg-RX-API-DMAC7.html)
CA (1) CA3163157A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021138682A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX377653B (es) 2013-03-15 2025-03-11 Orpro Therapeutics Inc Producto y uso para normalización de la viscoelasticidad del moco.
CA3187826A1 (en) * 2020-06-23 2021-12-30 Panasonic Intellectual Property Management Co., Ltd. Allergen inactivation method and allergen inactivation device
CN119317716A (zh) * 2022-07-05 2025-01-14 国立大学法人东北大学 抗病毒剂、用于治疗或者预防病毒感染症的药物组合物、病毒感染症的重症化风险的评价试剂盒以及病毒感染症的重症化风险的评价方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3515336C2 (de) * 1985-04-27 1994-01-20 Boehringer Ingelheim Int Verfahren zur Herstellung und Reinigung von â-Interferon
JPH10191977A (ja) * 1997-01-14 1998-07-28 Oriental Yeast Co Ltd チオレドキシン改変体及び該改変体を含むap−1の転写活性能を増強する因子
JP4758525B2 (ja) * 1998-03-20 2011-08-31 武田薬品工業株式会社 生理活性ポリペプチドの徐放性製剤およびその製造法
WO2004013283A2 (en) * 2002-08-02 2004-02-12 University Of Rochester Thioredoxin mutants and uses thereof
WO2004087917A1 (ja) * 2003-03-31 2004-10-14 National Institute Of Advanced Industrial Science And Technology チオレドキシン改変体
US20090203586A1 (en) * 2004-06-11 2009-08-13 Syngenta Limited Method for ameliorating an inflammatory skin condition
KR102374576B1 (ko) * 2011-05-17 2022-03-15 솔리제닉스, 인크. 열안정성 백신 조성물 및 그의 제조방법
MX377653B (es) * 2013-03-15 2025-03-11 Orpro Therapeutics Inc Producto y uso para normalización de la viscoelasticidad del moco.
WO2019222665A1 (en) * 2018-05-17 2019-11-21 Orpro Therapeutics, Inc. Thiol-based multivalent drug delivery compositions

Similar Documents

Publication Publication Date Title
JP7759693B2 (ja) モンテルカストおよびペプチドの新規接合体
AU2002351181B2 (en) Methods and compositions for treating lesions of the respiratory epithelium
JP2024010006A5 (cg-RX-API-DMAC7.html)
US20090227511A1 (en) Methods and compositions for treating lesions of the respiratory epithelium
JP2022500437A5 (cg-RX-API-DMAC7.html)
JP2026000993A (ja) 新ペプチド
JP2024170583A5 (cg-RX-API-DMAC7.html)
JP2024504225A5 (cg-RX-API-DMAC7.html)
JP2023126658A5 (cg-RX-API-DMAC7.html)
CN106456707B (zh) 干粉肽药剂
WO2024174948A1 (zh) 多肽pd-dp-005在制备治疗肺部疾病药物中的应用及其药物
CN114533706B (zh) 一种用于防治呼吸道疾病的雾化吸入制剂及其应用
US20240218016A1 (en) Peptides and their use in the treatment of inflammation
JP2016517446A5 (cg-RX-API-DMAC7.html)
US20120045479A1 (en) Dry Powder Formulations, Vaccines and Methods
Baugh et al. Infectious croup: a critical review
CN109200284B (zh) 一种猪支原体肺炎活疫苗黏膜免疫佐剂、制备方法及其应用
TW202017939A (zh) 貽貝黏著蛋白的抗病毒用途
JP2023524064A5 (cg-RX-API-DMAC7.html)
US20130281361A1 (en) Methods of treating and preventing rhinovirus infection
Mäkelä et al. Treatment of respiratory syncytial virus infections in children
HUT75660A (en) Novel remedy for respiratory-tract viral disease
JP2023517480A5 (cg-RX-API-DMAC7.html)
PRIGAL Studies with Medicated Aerosols: The Use of the Lungs as a Portal for the Introduction of Therapeutic Agents for Systemic Effect
Busey et al. The Treatment of Cystic Fibrosis: A Statement by the Committee on Therapy